268 related articles for article (PubMed ID: 35207609)
1. The Case for Clinical Trials with Novel GABAergic Drugs in Diabetes Mellitus and Obesity.
Antoni FA
Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207609
[TBL] [Abstract][Full Text] [Related]
2. Persistent therapeutic effect of a novel α5-GABA
Gacsályi I; Móricz K; Gigler G; Megyeri K; Machado P; Antoni FA
Eur J Pharmacol; 2018 Sep; 834():118-125. PubMed ID: 30012500
[TBL] [Abstract][Full Text] [Related]
3. GABA
Shen W; Nan C; Nelson PT; Ripps H; Slaughter MM
Physiol Rep; 2017 Mar; 5(6):. PubMed ID: 28348006
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of extra-synaptic α5-GABA
Etherington LA; Mihalik B; Pálvölgyi A; Ling I; Pallagi K; Kertész S; Varga P; Gunn BG; Brown AR; Livesey MR; Monteiro O; Belelli D; Barkóczy J; Spedding M; Gacsályi I; Antoni FA; Lambert JJ
Neuropharmacology; 2017 Oct; 125():353-364. PubMed ID: 28807671
[TBL] [Abstract][Full Text] [Related]
5. GABA Receptors: Pharmacological Potential and Pitfalls.
Jembrek MJ; Vlainic J
Curr Pharm Des; 2015; 21(34):4943-59. PubMed ID: 26365137
[TBL] [Abstract][Full Text] [Related]
6. Role of GABA receptor subtypes in inhibition of primate spinothalamic tract neurons: difference between spinal and periaqueductal gray inhibition.
Lin Q; Peng YB; Willis WD
J Neurophysiol; 1996 Jan; 75(1):109-23. PubMed ID: 8822545
[TBL] [Abstract][Full Text] [Related]
7. Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives.
Deidda G; Bozarth IF; Cancedda L
Front Cell Neurosci; 2014; 8():119. PubMed ID: 24904277
[TBL] [Abstract][Full Text] [Related]
8. Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors.
Candelario M; Cuellar E; Reyes-Ruiz JM; Darabedian N; Feimeng Z; Miledi R; Russo-Neustadt A; Limon A
J Ethnopharmacol; 2015 Aug; 171():264-72. PubMed ID: 26068424
[TBL] [Abstract][Full Text] [Related]
9. Behavioural pharmacology of the α5-GABA
Gacsályi I; Móricz K; Gigler G; Wellmann J; Nagy K; Ling I; Barkóczy J; Haller J; Lambert JJ; Szénási G; Spedding M; Antoni FA
Neuropharmacology; 2017 Oct; 125():30-38. PubMed ID: 28694097
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic and GABAergic receptor functional deficit in the hippocampus of insulin-induced hypoglycemic and streptozotocin-induced diabetic rats.
Sherin A; Anu J; Peeyush KT; Smijin S; Anitha M; Roshni BT; Paulose CS
Neuroscience; 2012 Jan; 202():69-76. PubMed ID: 22155651
[TBL] [Abstract][Full Text] [Related]
11. From GABAA receptor diversity emerges a unified vision of GABAergic inhibition.
Costa E
Annu Rev Pharmacol Toxicol; 1998; 38():321-50. PubMed ID: 9597158
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of GABA
Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
[TBL] [Abstract][Full Text] [Related]
13. [Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].
Ruetsch O; Viala A; Bardou H; Martin P; Vacheron MN
Encephale; 2005; 31(4 Pt 1):507-16. PubMed ID: 16389718
[TBL] [Abstract][Full Text] [Related]
14. mGlu₅-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia.
Wierońska JM; Kłeczek N; Woźniak M; Gruca P; Łasoń-Tyburkiewicz M; Papp M; Brański P; Burnat G; Pilc A
Neurochem Int; 2015 Sep; 88():97-109. PubMed ID: 25863284
[TBL] [Abstract][Full Text] [Related]
15. Loop-F of the α-subunit determines the pharmacologic profile of novel competitive inhibitors of GABA
Mihalik B; Pálvölgyi A; Bogár F; Megyeri K; Ling I; Barkóczy J; Bartha F; Martinek TA; Gacsályi I; Antoni FA
Eur J Pharmacol; 2017 Mar; 798():129-136. PubMed ID: 28153485
[TBL] [Abstract][Full Text] [Related]
16. The role of GABA in the mediation and perception of pain.
Enna SJ; McCarson KE
Adv Pharmacol; 2006; 54():1-27. PubMed ID: 17175808
[TBL] [Abstract][Full Text] [Related]
17. Biphasic modulation of parallel fibre synaptic transmission by co-activation of presynaptic GABAA and GABAB receptors in mice.
Howell RD; Pugh JR
J Physiol; 2016 Jul; 594(13):3651-66. PubMed ID: 27061582
[TBL] [Abstract][Full Text] [Related]
18. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
Engel M; Snikeris P; Matosin N; Newell KA; Huang XF; Frank E
Psychopharmacology (Berl); 2016 Apr; 233(8):1349-59. PubMed ID: 26861891
[TBL] [Abstract][Full Text] [Related]
19. GABA and its receptors in epilepsy.
Sperk G; Furtinger S; Schwarzer C; Pirker S
Adv Exp Med Biol; 2004; 548():92-103. PubMed ID: 15250588
[TBL] [Abstract][Full Text] [Related]
20. GABA
Felice D; Cryan JF; O'Leary OF
Curr Top Behav Neurosci; 2022; 52():241-265. PubMed ID: 32860591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
